Lugano Financial Advisors SA (LFA)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$198K Hold
1,018
0.12% 84
2026
Q1
$229K Hold
1,018
0.12% 71
2025
Q4
$245K Buy
1,018
+37
+4% +$9.46K 0.13% 71
2025
Q3
$269K Buy
981
+127
+15% +$34.7K 0.14% 67
2025
Q2
$220K Buy
854
+137
+19% +$32.7K 0.13% 71
2025
Q1
$161K Sell
717
-33
-4% -$7.7K 0.11% 80
2024
Q4
$172K Buy
750
+403
+116% +$97K 0.11% 79
2024
Q3
$84.7K Buy
347
+35
+11% +$7.82K 0.06% 122
2024
Q2
$59.7K Buy
+312
New +$63.3K 0.05% 127

Other funds holding RMD

Lugano Financial Advisors SA (LFA)'s RMD Position: Q2 2026 in Review

Lugano Financial Advisors SA (LFA) held its ResMed (RMD) position steady in Q2 2026 at 1,018 shares worth $198K. The position accounts for 0.12% of the portfolio, ranked #84.

Lugano Financial Advisors SA (LFA) first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $269K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Lugano Financial Advisors SA (LFA) held 1,018 shares of ResMed worth $198K as of Q2 2026.
  • Lugano Financial Advisors SA (LFA) left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.12% of Lugano Financial Advisors SA (LFA)'s portfolio in Q2 2026, its #84 holding.
  • Lugano Financial Advisors SA (LFA) first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • Lugano Financial Advisors SA (LFA)'s ResMed position peaked at $269K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Lugano Financial Advisors SA (LFA)'s 13F filing for Q2 2026, filed 28 Jul 2026.